Thomas A. Hope, MD


Dr. Thomas Hope is a radiologist and nuclear medicine physician specializing in neuroendocrine tumors, with a focus on treating patients with peptide receptor radionuclide therapy, or PRRT. He has a special interest in molecular imaging and in treating cancer patients using targeted imaging and paired therapies, also called theranostics.

In addition to working with patients, Hope conducts research focusing on novel radiopharmaceuticals, or new radioactive imaging agents that can help physicians localize tumors using positron emission tomography (PET). He also works on combining different imaging modalities — such as PET and MRI — to stage cancers in patients.

Hope received his medical degree from Stanford University School of Medicine, followed by a residency in diagnostic radiology at UCSF. He then completed a fellowship in nuclear medicine and body MRI at Stanford. Hope is a member of the Radiological Society of North America, the Society of Nuclear Medicine and Molecular Imaging, the Society of Abdominal Radiology, and the International Society for Magnetic Resonance in Medicine. He is an assistant professor at UCSF.


Gastrointestinal Medical Oncology Clinic
1825 Fourth St., Fourth Floor
San Francisco, CA 94158
Phone: (415) 353-9888
Fax: (415) 353-9931

Hours: Monday to Friday
8 a.m. – 5 p.m.

Board Certification

Nuclear Medicine, American Board of Nuclear Medicine

Academic Title

Associate Professor

More about Thomas A. Hope


Stanford University School of Medicine 2007


UCSF Medical Center, Diagnostic Radiology 2012


Stanford Hospital and Clinics, Nuclear Medicine and Body MRI 2013

Selected Research and Publications

  1. Wangerin KA, Baratto L, Khalighi MM, Hope TA, Gulaka PK, Deller TW, Iagaru AH. Clinical Evaluation of 68Ga-PSMA-II and 68Ga-RM2 PET Images Reconstructed With an Improved Scatter Correction Algorithm. AJR Am J Roentgenol. 2018 Jun 06; 1-6.
  2. Hicks RM, Loening AM, Ohliger MA, Vasanawala SS, Hope TA. Variable refocusing flip angle single-shot fast spin echo imaging of liver lesions: increased speed and lesion contrast. Abdom Radiol (NY). 2018 Mar; 43(3):593-599.
  3. Wiesinger F, Bylund M, Yang J, Kaushik S, Shanbhag D, Ahn S, Jonsson JH, Lundman JA, Hope T, Nyholm T, Larson P, Cozzini C. Zero TE-based pseudo-CT image conversion in the head and its application in PET/MR attenuation correction and MR-guided radiation therapy planning. Magn Reson Med. 2018 Feb 18.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.